November 8, 2017 06:48 AM ESTUpdated May 26, 08:50 PM

How much is your vision worth? Spark CEO Jeff Marrazzo has a price in mind

John Carroll

Editor & Founder

Just how much is your vision worth?

That’s the billion-dollar question at Spark Therapeutics now as the FDA winds up with an odds-on approval for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

FDA approves Moderna’s next-gen Covid vaccine, with limits on most healthy people

Summit says bispecific misses overall survival in closely-watched lung cancer study

Summit’s disappointing survival readout raises stakes for full data

Gilead, Merck reveal 'practice-changing' data for Trodelvy-Keytruda combo in aggressive breast cancer

Arvinas, Pfizer's PROTAC in breast cancer no better than oral SERDs

sponsored

From weeks to days: how Aizon Intelligent Agents transform pharma validation